Under pathological conditions, the dysregulation of metabolic enzyme activity in the kynurenine pathway, such as increased IDO expression and imbalance in metabolite levels, leads to immune activation and activation of inflammatory pathways, which play a critical role in the progression of liver diseases. This evidence concerns the gene IDO1 and liver disorder.